Early highly active antiretroviral therapy enhances B-cell longevity: a 5 year follow up.

Cagigi, Alberto

Early highly active antiretroviral therapy enhances B-cell longevity: a 5 year follow up. [electronic resource] - The Pediatric infectious disease journal May 2014 - e126-31 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1532-0987

10.1097/INF.0000000000000144 doi


Adolescent
Anti-Retroviral Agents--administration & dosage
Antibodies--blood
Antiretroviral Therapy, Highly Active--methods
B-Lymphocytes--immunology
Cell Survival
Child
Enzyme-Linked Immunosorbent Assay
Enzyme-Linked Immunospot Assay
Female
Flow Cytometry
Follow-Up Studies
HIV Infections--drug therapy
Humans
Male
Time Factors
Vaccines--administration & dosage
Young Adult